CDH17/Cadherin 17, His, Cynomolgus
| ¥3800 | |
| Z04763-100 | |
|
|
|
|
|
|
|
|
|
| ¥3800 | |
| Z04763-100 | |
|
|
|
|
|
|
|
|
|
| Species | Cynomolgus | ||||
| Protein Construction |
|
||||
| Purity | > 90% as determined by BisTris PAGE | ||||
| Endotoxin Level | Less than 1 EU per μg by the LAL method. | ||||
| Biological Activity | Measured by its binding ability in a functional ELISA.Test result was comparable to standard batch. | ||||
| Expression System | HEK293 | ||||
| Theoretical Molecular Weight | 85.57 kDa | ||||
| Apparent Molecular Weight | Due to glycosylation, the protein migrates to 95-115 kDa based on Bis-Tris PAGE result. | ||||
| Formulation | Lyophilized from 0.22 μm filtered solution in PBS (pH 7.4). | ||||
| Reconstitution | Centrifuge the tube before opening. Reconstituting to a concentration more than 100 μg/ml is recommended. Dissolve the lyophilized protein in distilled water. | ||||
| Storage & Stability | Upon receiving, the product remains stable for 6 months at -20℃ or below. Upon reconstitution, the product should be stable for 3 months at -80℃. Avoid repeated freeze-thaw cycles. |
Loaded Anti-CDH17 Ab., hFc-Avi Tag on ProA-Biosensor can bind CDH17/Cadherin 17, His, Cynomolgus, His Tag with an affinity constant of 9.78 nM as determined in BLI assay (Gator® Prime). »
Immobilized CDH17/Cadherin 17, His, Cynomolgus, His Tag at 1 μg/ml (100 μI/well) on the plate. Dose response curve for Anti-CDH17 Antibody, hFc Tag with the EC50 of 3.4ng/ml determined by ELISA. »
The purity of CDH17/Cadherin 17, His, Cynomolgus is greater than 90% as determined by SEC-HPLC. »
CDH17/Cadherin 17, His, Cynomolgus on Bis-Tris PAGE under reduced condition. The purity is greater than 90%. »
| Target Background | Liver-intestine cadherin (CDH17) has been known to function as a tumor stimulator and diagnostic marker for almost two decades.In vivo studies showed CDH17 knockout resulted in apoptotic PC tumor death through activating caspase-3 activity. Taken together, CDH17 functions as an oncogenic molecule critical to PC growth by regulating tumor apoptosis signaling pathways and CDH17 could be targeted to develop an anti-PC therapeutic approach. |
| Synonyms | Cadherin-17; BILL-cadherin; LI-cadherin; P130; Cdh17; CDH16; HPT-1; cadherin-16 |
For research use only. Not intended for human or animal clinical trials, therapeutic or diagnostic use.